Abdominal Pain News - LARVOL Sigma

Abdominal Pain

Welcome, Profile Billing Logout

20 Mechanisms of Action

|||||||||| New P1/2 trial: Spinal Cord Stimulation for Pain Relief in Irritable Bowel Syndrome (clinicaltrials.gov) - Nov 13, 2012
P1/2, N=10, Completed, Sponsor: Uppsala University

||||||||||  Sandostatin LAR Depot (octreotide acetate) / Novartis
Trial completion:  Octreotide in Severe Polycystic Liver Disease (clinicaltrials.gov) -  Oct 21, 2012
P2/3, N=42, Completed,  Sponsor: Mayo Clinic
Active, not recruiting --> Completed

|||||||||| Trial initiation date: Adhesiolysis in Chronic Abdominal Pain (clinicaltrials.gov) - Oct 15, 2012
P=N/A, N=0, Withdrawn, Sponsor: North Karelia Central Hospital
Active, not recruiting --> Completed Initiation date: Jan 2013 --> Jan 2014

|||||||||| Enrollment change: Evaluation of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children (clinicaltrials.gov) - Sep 25, 2012
P1/2, N=8, Completed, Sponsor: Huang, Jeannie, M.D.
Initiation date: Jan 2013 --> Jan 2014 N=30 --> 8

|||||||||| Trial completion: Evaluation of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children (clinicaltrials.gov) - Sep 25, 2012
P1/2, N=8, Completed, Sponsor: Huang, Jeannie, M.D.
N=30 --> 8 Recruiting --> Completed

|||||||||| Clinical: Study of Yili "Changqing" Pro-ABB Yoghurt in the Improvement of Human Gastrointestinal Tract System (clinicaltrials.gov) - Sep 9, 2012
P=N/A, N=400, Completed, Sponsor: Inner Mongolia Yili Industrial Group Co., Ltd

|||||||||| New P4 trial: Study Comparing Early Laparoscopy With Active Observation in Acute Non-specific Abdominal Pain (clinicaltrials.gov) - Aug 28, 2012
P4, N=17, Terminated, Sponsor: Mid Western Regional Hospital, Ireland

|||||||||| New P2 trial: A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain (clinicaltrials.gov) - Aug 27, 2012
P2, N=40, Recruiting, Sponsor: University of Michigan

|||||||||| New P1/2 trial: Acupuncture Treatment for Gastroparesis: a Pilot Study (clinicaltrials.gov) - Jul 16, 2012
P1/2, N=20, Recruiting, Sponsor: Johns Hopkins University

|||||||||| Trial completion: COCE: Safety and Efficacy of Carbon Dioxide Insufflation During Colonoscopy With Consecutive Esophagogastroduodenoscopy in Reduction of Abdominal Pain in Sedated Outpatients (clinicaltrials.gov) - Jun 23, 2012
P3, N=100, Completed, Sponsor: Inje University
Recruiting --> Completed Not yet recruiting --> Completed

|||||||||| Trial initiation date: Effect of Probiotics in Childhood Abdominal Pain (clinicaltrials.gov) - Jun 12, 2012
P=N/A, N=100, Not yet recruiting, Sponsor: Soroka University Medical Center
Not yet recruiting --> Completed Initiation date: Sep 2010 --> Jan 2013

||||||||||  nortriptyline / Generic mfg.
Enrollment change, HEOR:  Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia (clinicaltrials.gov) -  Jun 6, 2012
P=N/A, N=5, Terminated,  Sponsor: Cleveland Clinic Florida
Initiation date: Sep 2010 --> Jan 2013 N=72 --> 5

|||||||||| Trial completion: A Six-month Study to Compare Outcome Differences and Visceral Response ... Irritable Bowel Syndrome (clinicaltrials.gov) - May 20, 2012
P=N/A, N=163, Completed, Sponsor: University of California, Los Angeles
N=72 --> 5 Active, not recruiting --> Completed

||||||||||  Ilaris (canakinumab) / Novartis
Enrollment closed:  Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS). (clinicaltrials.gov) -  May 6, 2012
P2, N=20, Active, not recruiting,  Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Active, not recruiting

||||||||||  esomeprazole / Generic mfg.
Trial termination:  Viokase 16, Viokase16 Plus Nexium and Nexium Alone (clinicaltrials.gov) -  Mar 25, 2012
P1, N=12, Terminated,  Sponsor: University of Florida
Recruiting --> Active, not recruiting Recruiting --> Terminated; Viokase was taken off market during study and remained off over a year.

||||||||||  esomeprazole / Generic mfg.
Enrollment change:  Viokase 16, Viokase16 Plus Nexium and Nexium Alone (clinicaltrials.gov) -  Mar 25, 2012
P1, N=12, Terminated,  Sponsor: University of Florida
Recruiting --> Terminated; Viokase was taken off market during study and remained off over a year. N=24 --> 12

||||||||||  pregabalin / Generic mfg.
Enrollment change:  Pregabalin for Abdominal Pain From Adhesions (clinicaltrials.gov) -  Mar 21, 2012
P4, N=18, Terminated,  Sponsor: Henry Ford Health System
N=24 --> 12 N=100 --> 18

||||||||||  dronabinol oral / Generic mfg.
New P2 trial:  The Analgesic Efficacy of ?9-THC (Namisol (clinicaltrials.gov) -  Mar 21, 2012
P2, N=68, Recruiting,  Sponsor: Radboud University

||||||||||  dronabinol oral / Generic mfg.
New P2 trial:  ?9-THC (Namisol (clinicaltrials.gov) -  Mar 8, 2012
P2, N=68, Recruiting,  Sponsor: Radboud University

||||||||||  deferasirox tablet for oral suspension / Generic mfg.
Trial initiation date:  MACS1574: Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study (clinicaltrials.gov) -  Feb 29, 2012
P4, N=12, Terminated,  Sponsor: Novartis Pharmaceuticals
N=100 --> 18 Initiation date: Jul 2011 --> Dec 2011

||||||||||  azithromycin / Generic mfg.
New P3 trial:  Concisus2012: Trial Of Azithromycin In Campylobacter Concisus Patients With Diarrhea (clinicaltrials.gov) -  Feb 8, 2012
P3, N=100, Recruiting,  Sponsor: University of Aarhus

||||||||||  dronabinol oral / Generic mfg.
Trial initiation date:  Delta-pain: Efficacy Study of ?9-THC to Treat Chronic Abdominal Pain (clinicaltrials.gov) -  Feb 6, 2012
P2, N=24, Completed,  Sponsor: Radboud University
Initiation date: Jul 2011 --> Dec 2011 Initiation date: May 2011 --> Oct 2011

||||||||||  trimebutine maleate / Generic mfg.
New P4 trial:  Comparative Efficacy and Safety of Fenoverine (clinicaltrials.gov) -  Jan 9, 2012
P4, N=186, Recruiting,  Sponsor: Bukwang Pharmaceutical

|||||||||| New P4 trial: Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood (clinicaltrials.gov) - Dec 18, 2011
P4, N=90, Completed, Sponsor: Medical University of Warsaw

||||||||||  quetiapine extended-release / Generic mfg.
Enrollment closed:  Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder (clinicaltrials.gov) -  Dec 5, 2011
P=N/A, N=50, Active, not recruiting,  Sponsor: Douglas A Drossman, MD
Initiation date: May 2011 --> Oct 2011 Recruiting --> Active, not recruiting

||||||||||  Savella (milnacipran) / AbbVie, Pierre Fabre
New P2 trial:  Milnacipran (Savella) in Irritable Bowel Syndrome (IBS) (clinicaltrials.gov) -  Nov 14, 2011
P2, N=2, Terminated,  Sponsor: Spencer Dorn, MD, MPH

|||||||||| Enrollment open: Plain Magnetic Resonance (MR) in the Assessment of Patients With Acute Abdomen (clinicaltrials.gov) - Oct 24, 2011
P=N/A, N=150, Recruiting, Sponsor: Koege Sygehus
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting

|||||||||| New P3 trial: COCE: Safety and Efficacy of Carbon Dioxide Insufflation During Colonoscopy With Consecutive Esophagogastroduodenoscopy in Reduction of Abdominal Pain in Sedated Outpatients (clinicaltrials.gov) - Oct 10, 2011
P3, N=100, Completed, Sponsor: Inje University

|||||||||| Enrollment open: Internet Intervention for Adolescents With Chronic Pain (clinicaltrials.gov) - Oct 10, 2011
P2, N=600, Recruiting, Sponsor: Seattle Children's Hospital
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting